Literature DB >> 11500394

CD4+ T helper 1 cells facilitate regression of murine Lyme carditis.

L K Bockenstedt1, I Kang, C Chang, D Persing, A Hayday, S W Barthold.   

Abstract

Murine Lyme borreliosis, caused by infection with the spirochete Borrelia burgdorferi, results in acute arthritis and carditis that regress as a result of B. burgdorferi-specific immune responses. B. burgdorferi-specific antibodies can attenuate arthritis in mice deficient in both B cells and T cells but have no effect on carditis. Because macrophages comprise the principal immune cell in carditis, T-cell responses that augment cell-mediated immunity may be important for carditis regression. To investigate this hypothesis, we examined the course of Lyme carditis in mice selectively deficient in B cells or alphabeta T cells. Our results show that carditis regresses in B-cell-deficient B10.A(k) mice but not in alphabeta T-cell-deficient mice, independently of the mouse strain background. Despite prominent macrophage infiltrates, hearts from B. burgdorferi-infected alphabeta T-cell-deficient mice had less mRNA for tumor necrosis factor alpha as measured by reverse transcription-PCR compared to infected control mice. Anti-inflammatory cytokine mRNA levels were equivalent. Adoptive transfer of gamma interferon-secreting CD4+ T cells into infected alphabeta T-cell-deficient mice promoted carditis resolution. These results show that alphabeta T cells can promote resolution of murine Lyme carditis and are the first demonstration of a beneficial role for CD4+ T helper 1 cells in this disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11500394      PMCID: PMC98634          DOI: 10.1128/IAI.69.9.5264-5269.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Lymphoid development in mice congenitally lacking T cell receptor alpha beta-expressing cells.

Authors:  K L Philpott; J L Viney; G Kay; S Rastan; E M Gardiner; S Chae; A C Hayday; M J Owen
Journal:  Science       Date:  1992-06-05       Impact factor: 47.728

2.  Kinetics of Borrelia burgdorferi dissemination and evolution of disease after intradermal inoculation of mice.

Authors:  S W Barthold; D H Persing; A L Armstrong; R A Peeples
Journal:  Am J Pathol       Date:  1991-08       Impact factor: 4.307

3.  Lyme borreliosis in the severe combined immunodeficiency (scid) mouse manifests predominantly in the joints, heart, and liver.

Authors:  U E Schaible; S Gay; C Museteanu; M D Kramer; G Zimmer; K Eichmann; U Museteanu; M M Simon
Journal:  Am J Pathol       Date:  1990-10       Impact factor: 4.307

4.  Lyme borreliosis in selected strains and ages of laboratory mice.

Authors:  S W Barthold; D S Beck; G M Hansen; G A Terwilliger; K D Moody
Journal:  J Infect Dis       Date:  1990-07       Impact factor: 5.226

5.  Passive immunizing activity of sera from mice infected with Borrelia burgdorferi.

Authors:  S W Barthold; L K Bockenstedt
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

6.  Chronic Lyme borreliosis in the laboratory mouse.

Authors:  S W Barthold; M S de Souza; J L Janotka; A L Smith; D H Persing
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

7.  Carditis in Lyme disease susceptible and resistant strains of laboratory mice infected with Borrelia burgdorferi.

Authors:  A L Armstrong; S W Barthold; D H Persing; D S Beck
Journal:  Am J Trop Med Hyg       Date:  1992-08       Impact factor: 2.345

8.  Lyme borreliosis in genetically resistant and susceptible mice with severe combined immunodeficiency.

Authors:  S W Barthold; C L Sidman; A L Smith
Journal:  Am J Trop Med Hyg       Date:  1992-11       Impact factor: 2.345

9.  Borrelia burgdorferi activates a T helper type 1-like T cell subset in Lyme arthritis.

Authors:  H Yssel; M C Shanafelt; C Soderberg; P V Schneider; J Anzola; G Peltz
Journal:  J Exp Med       Date:  1991-09-01       Impact factor: 14.307

10.  The T helper cell response in Lyme arthritis: differential recognition of Borrelia burgdorferi outer surface protein A in patients with treatment-resistant or treatment-responsive Lyme arthritis.

Authors:  B Lengl-Janssen; A F Strauss; A C Steere; T Kamradt
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

View more
  28 in total

1.  Macrophage p38 mitogen-activated protein kinase activity regulates invariant natural killer T-cell responses during Borrelia burgdorferi infection.

Authors:  Kelly Hawley; Nicolás Navasa; Chris M Olson; Tonya C Bates; Renu Garg; Michael N Hedrick; Dietrich Conze; Mercedes Rincón; Juan Anguita
Journal:  J Infect Dis       Date:  2012-05-02       Impact factor: 5.226

2.  BB0238, a presumed tetratricopeptide repeat-containing protein, is required during Borrelia burgdorferi mammalian infection.

Authors:  Ashley M Groshong; Danielle E Fortune; Brendan P Moore; Horace J Spencer; Robert A Skinner; William T Bellamy; Jon S Blevins
Journal:  Infect Immun       Date:  2014-07-28       Impact factor: 3.441

3.  CD4+ T cells promote antibody production but not sustained affinity maturation during Borrelia burgdorferi infection.

Authors:  Rebecca A Elsner; Christine J Hastey; Nicole Baumgarth
Journal:  Infect Immun       Date:  2014-10-13       Impact factor: 3.441

4.  Cerebrospinal fluid-infiltrating CD4+ T cells recognize Borrelia burgdorferi lysine-enriched protein domains and central nervous system autoantigens in early lyme encephalitis.

Authors:  Jan D Lünemann; Harald Gelderblom; Mireia Sospedra; Jacqueline A Quandt; Clemencia Pinilla; Adriana Marques; Roland Martin
Journal:  Infect Immun       Date:  2006-10-23       Impact factor: 3.441

5.  Localized production of IL-10 suppresses early inflammatory cell infiltration and subsequent development of IFN-γ-mediated Lyme arthritis.

Authors:  F Lynn Sonderegger; Ying Ma; Heather Maylor-Hagan; James Brewster; Xiaosong Huang; Gerald J Spangrude; James F Zachary; John H Weis; Janis J Weis
Journal:  J Immunol       Date:  2011-12-16       Impact factor: 5.422

Review 6.  Sleeper cells: the stringent response and persistence in the Borreliella (Borrelia) burgdorferi enzootic cycle.

Authors:  Felipe C Cabello; Henry P Godfrey; Julia V Bugrysheva; Stuart A Newman
Journal:  Environ Microbiol       Date:  2017-09-11       Impact factor: 5.491

7.  Detection of established virulence genes and plasmids to differentiate Borrelia burgdorferi strains.

Authors:  Kamfai Chan; Sherwood Casjens; Nikhat Parveen
Journal:  Infect Immun       Date:  2012-01-30       Impact factor: 3.441

8.  Marginal zone B-cell depletion impairs murine host defense against Borrelia burgdorferi infection.

Authors:  Alexia A Belperron; Catherine M Dailey; Carmen J Booth; Linda K Bockenstedt
Journal:  Infect Immun       Date:  2007-04-30       Impact factor: 3.441

Review 9.  Severe course of Lyme neuroborreliosis in an HIV-1 positive patient; case report and review of the literature.

Authors:  Nathalie D van Burgel; Mayke Oosterloo; Frank P Kroon; Alje P van Dam
Journal:  BMC Neurol       Date:  2010-11-30       Impact factor: 2.474

10.  A chromosomally encoded virulence factor protects the Lyme disease pathogen against host-adaptive immunity.

Authors:  Xiuli Yang; Adam S Coleman; Juan Anguita; Utpal Pal
Journal:  PLoS Pathog       Date:  2009-03-06       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.